Agios Pharma (AGIO) Tops Q1 EPS by 15c, Beat on Revenues

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.56), $0.15 better than the analyst estimate of ($1.71). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $8.07 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
• Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance